Akebia Therapeutics (AKBA) Short Interest Ratio & Short Volume $3.65 +0.08 (+2.24%) As of 06/12/2025 04:00 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Akebia Therapeutics Short Interest DataAkebia Therapeutics (AKBA) has a short interest of 20.05 million shares, representing 9.58% of the float (the number of shares available for trading by the public). This marks a 1.67% increase in short interest from the previous month. The short interest ratio (days to cover) is 3.6, indicating that it would take 3.6 days of the average trading volume of 3.16 million shares to cover all short positions.Current Short Interest20,050,000 sharesPrevious Short Interest19,720,000 sharesChange Vs. Previous Month+1.67%Dollar Volume Sold Short$60.75 millionShort Interest Ratio3.6 Days to CoverLast Record DateMay 31, 2025Outstanding Shares262,636,000 sharesShort Percent of Float9.58%Today's Trading Volume4,112,555 sharesAverage Trading Volume3,162,558 sharesToday's Volume Vs. Average130% Short Selling Akebia Therapeutics? Sign up to receive the latest short interest report for Akebia Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartAKBA Short Interest Over TimeAKBA Days to Cover Over TimeAKBA Percentage of Float Shorted Over Time Akebia Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/31/202520,050,000 shares $60.75 million +1.7%9.6%3.6 $3.03 5/15/202519,720,000 shares $50.09 million +11.0%9.4%4.2 $2.54 4/30/202517,770,000 shares $42.83 million -0.8%N/A4.3 $2.41 4/15/202517,920,000 shares $33.87 million +3.2%8.6%4.7 $1.89 3/31/202517,360,000 shares $33.33 million +4.8%8.3%4.7 $1.92 3/15/202516,570,000 shares $37.45 million +11.4%7.9%5 $2.26 2/28/202514,880,000 shares $27.53 million -0.7%7.1%6.8 $1.85 2/15/202514,980,000 shares $31.91 million +3.7%7.2%6.8 $2.13 1/31/202514,450,000 shares $32.37 million -19.7%N/A6.4 $2.24 1/15/202517,990,000 shares $34.90 million +7.9%N/A7.3 $1.94 Get the Latest News and Ratings for AKBA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Akebia Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/31/202416,680,000 shares $31.69 million +18.6%N/A7.9 $1.90 12/15/202414,070,000 shares $26.03 million +21.7%N/A7.1 $1.85 11/30/202411,560,000 shares $23.81 million -3.3%N/A6.2 $2.06 11/15/202411,960,000 shares $21.41 million -19.4%N/A6.5 $1.79 10/31/202414,840,000 shares $24.63 million -16.1%N/A8.1 $1.66 10/15/202417,680,000 shares $23.16 million -6.0%N/A10.6 $1.31 9/30/202418,800,000 shares $24.82 million -1.4%N/A10.1 $1.32 9/15/202419,060,000 shares $27.83 million -0.1%N/A7.2 $1.46 8/31/202419,070,000 shares $29.56 million +0.6%N/A6.9 $1.55 8/15/202418,950,000 shares $27.29 million +5.9%N/A6.6 $1.44 7/31/202417,890,000 shares $24.69 million -4.1%N/A5.9 $1.38 7/15/202418,660,000 shares $24.44 million +42.3%N/A5.8 $1.31 6/30/202413,110,000 shares $13.37 million +6.6%N/A4 $1.02 6/15/202412,300,000 shares $13.16 million -6.5%N/A2.7 $1.07 5/31/202413,160,000 shares $14.74 million +12.5%N/A2.7 $1.12 5/15/202411,700,000 shares $13.81 million -1.4%N/A2.3 $1.18 4/30/202411,860,000 shares $14.94 million -13.4%N/A2.4 $1.26 4/15/202413,690,000 shares $19.03 million +2.2%N/A2.9 $1.39 3/31/202413,400,000 shares $24.52 million +32.3%N/A3 $1.83 3/15/202410,130,000 shares $17.22 million +24.9%N/A3.4 $1.70 2/29/20248,110,000 shares $12.81 million +1.4%N/A4 $1.58 2/15/20248,000,000 shares $11.76 million -8.9%N/A4.5 $1.47 1/31/20248,780,000 shares $14.75 million +12.1%N/A5.4 $1.68 1/15/20247,830,000 shares $12.14 million -0.5%N/A5 $1.55 12/31/20237,870,000 shares $9.76 million +7.4%N/A5.3 $1.24 12/15/20237,330,000 shares $8.43 million -18.7%N/A5.5 $1.15 11/30/20239,010,000 shares $9.55 million -8.8%N/A6.9 $1.06 11/15/20239,880,000 shares $9.88 million -4.3%N/A6.8 $1.00 10/31/202310,320,000 shares $9.08 million +33.2%N/A6.8 $0.88 10/15/20237,750,000 shares $7.03 million +6.5%N/A4.5 $0.91Market Panic: Trump Just Dropped a Bomb on Your Stocks (Ad)tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.Don't wait for the next drop to wipe you out. Get the FREE Guide Before Markets Open Tomorrow 9/30/20237,280,000 shares $8.30 million +0.7%N/A4.4 $1.14 9/15/20237,230,000 shares $9.11 million +24.4%N/A4.1 $1.26 8/31/20235,810,000 shares $8.08 million -14.1%N/A3.1 $1.39 8/15/20236,760,000 shares $8.86 million +10.3%N/A3.2 $1.31 7/31/20236,130,000 shares $10.24 million +13.7%N/A2.8 $1.67 7/15/20235,390,000 shares $5.71 million +11.4%N/A2.9 $1.06 6/30/20234,840,000 shares $4.43 million +11.3%N/A2.7 $0.92 6/15/20234,350,000 shares $4.96 million -15.5%N/A2.5 $1.14 5/31/20235,150,000 shares $5.36 million +26.5%N/A3 $1.04 5/15/20234,070,000 shares $4.44 million -9.6%N/A2.4 $1.09 4/30/20234,500,000 shares $4.09 million -20.8%N/A2.4 $0.91 4/15/20235,680,000 shares $3.57 million +0.4%N/A2.9 $0.63 3/31/20235,660,000 shares $3.17 million -15.3%N/A2.8 $0.56 3/15/20236,680,000 shares $4.49 million -20.3%N/A3 $0.67 2/28/20238,380,000 shares $7.06 million +82.6%N/A3.5 $0.84 2/15/20234,590,000 shares $4.07 million +38.3%N/A2 $0.89 1/31/20233,320,000 shares $2.09 million -28.1%N/A1.7 $0.63 1/15/20234,620,000 shares $3.21 million -0.9%N/A2.7 $0.70 12/30/20224,660,000 shares $2.69 million -0.4%N/A2.7 $0.58 12/15/20224,680,000 shares $2.12 million -2.9%N/A3.1 $0.45 11/30/20224,820,000 shares $1.30 million -12.5%N/A3.4 $0.27 11/15/20225,510,000 shares $1.41 million -6.9%N/A3.8 $0.26 10/31/20225,920,000 shares $1.51 million -5.9%N/A3.4 $0.25 10/15/20226,290,000 shares $1.82 million -13.4%N/A2.7 $0.29 9/30/20227,260,000 shares $2.30 million -5.8%N/A2.6 $0.32 9/15/20227,710,000 shares $2.85 million -3.5%N/A1.1 $0.37 8/31/20227,990,000 shares $2.91 million -14.5%N/A1 $0.36 8/15/20229,340,000 shares $3.87 million -18.5%N/A1 $0.41 7/31/202211,460,000 shares $4.48 million +1.4%N/A1.1 $0.39 7/15/202211,300,000 shares $4.77 million +19.5%N/A1 $0.42 6/30/20229,460,000 shares $3.34 million -39.6%N/A0.7 $0.35 6/15/202215,660,000 shares $5.53 million -11.9%N/A1.2 $0.35 5/31/202217,780,000 shares $6.58 million -8.1%N/A1.5 $0.37 5/15/202219,340,000 shares $8.68 million +1.2%N/A1.8 $0.45 4/30/202219,120,000 shares $7.94 million +12.3%N/A1.9 $0.42 4/15/202217,020,000 shares $9.16 million -20.5%N/A1.9 $0.54 3/31/202221,410,000 shares $15.37 million +44.1%N/A3 $0.72 3/15/202214,860,000 shares $34.18 million +12.9%N/A3.8 $2.30 2/28/202213,160,000 shares $28.43 million +7.6%N/A3.5 $2.16 2/15/202212,230,000 shares $22.38 million +9.0%N/A3.6 $1.83 1/31/202211,220,000 shares $22.33 million +9.9%N/A3.5 $1.99 1/15/202210,210,000 shares $22.46 million -10.0%N/A3.4 $2.20 12/31/202111,350,000 shares $25.65 million -4.2%N/A4.1 $2.26 12/15/202111,850,000 shares $29.03 million +4.1%N/A4.6 $2.45 11/30/202111,380,000 shares $30.84 million +10.3%N/A5.5 $2.71 11/15/202110,320,000 shares $29.62 million -11.2%N/A5.1 $2.87 10/29/202111,620,000 shares $33.35 million +1.9%N/A5.8 $2.87 10/15/202111,400,000 shares $32.49 million -10.2%N/A5.3 $2.85 9/30/202112,690,000 shares $36.55 million +1.5%N/A4.1 $2.88 9/15/202112,500,000 shares $34.75 million -6.6%N/A3.9 $2.78"I'm risking my reputation on this" (Ad)Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the same signals. They're positioning themselves for something unprecedented. And after 17 million podcast downloads and over 600 insider interviews, I finally connected all the dots… What I discovered was so explosive, so potentially life-changing, that I had to put it all in a book.Claim your FREE copy of Crypto Revolution now. 8/31/202113,380,000 shares $39.34 million +2.8%N/A3.7 $2.94 8/13/202113,010,000 shares $32.79 million -6.9%N/A3.4 $2.52 7/30/202113,980,000 shares $34.53 million -11.0%N/A3.6 $2.47 7/15/202115,700,000 shares $52.12 million +2.9%10.3%4.1 $3.32 6/30/202115,260,000 shares $57.84 million -2.2%10.0%4.6 $3.79 6/15/202115,610,000 shares $54.95 million -3.0%10.2%4.5 $3.52 5/28/202116,090,000 shares $56.48 million -11.7%10.6%4.5 $3.51 5/14/202118,220,000 shares $60.67 million -0.3%N/A4.3 $3.33 4/30/202118,280,000 shares $59.41 million -7.2%N/A3.6 $3.25 4/15/202119,690,000 shares $61.33 million -7.6%N/A3.3 $3.12 3/31/202121,300,000 shares $65.92 million -15.2%N/A3.3 $3.10 3/15/202125,130,000 shares $90.72 million -1.5%N/A3.7 $3.61 2/26/202125,500,000 shares $88.49 million -3.2%N/A3.7 $3.47 2/12/202126,350,000 shares $125.69 million -4.0%N/A4 $4.77 1/29/202127,450,000 shares $94.02 million -4.8%N/A4.4 $3.43 1/15/202128,820,000 shares $91.36 million +0.5%N/A4.5 $3.17 12/31/202028,680,000 shares $85.75 million +20.9%N/A4.4 $2.99 12/15/202023,730,000 shares $75.46 million +0.8%N/A3.7 $3.18 11/30/202023,540,000 shares $79.80 million -6.2%N/A3.3 $3.39 11/15/202025,100,000 shares $63.75 million -6.1%N/A3 $2.54 10/30/202026,730,000 shares $60.68 million +7.7%N/A3.4 $2.27 10/15/202024,830,000 shares $88.89 million +12.0%N/A3.7 $3.58 9/30/202022,170,000 shares $55.65 million +141.8%N/A4.3 $2.51 9/15/20209,170,000 shares $24.21 million +12.4%N/A2 $2.64 8/31/20208,160,000 shares $84.95 million -10.0%N/A2.4 $10.41 8/14/20209,070,000 shares $95.51 million -5.2%N/A6.9 $10.53 7/31/20209,570,000 shares $106.90 million -1.8%N/A6.5 $11.17 7/15/20209,740,000 shares $120.29 million +1.0%N/A5.6 $12.35 6/30/20209,640,000 shares $122.43 million +61.5%N/A5.5 $12.70 6/15/20205,970,000 shares $72.42 million +18.5%N/A3.7 $12.13 AKBA Short Interest - Frequently Asked Questions What is Akebia Therapeutics' current short interest? Short interest is the volume of Akebia Therapeutics shares that have been sold short but have not yet been covered or closed out. As of May 31st, investors have sold 20,050,000 shares of AKBA short. 9.58% of Akebia Therapeutics' shares are currently sold short. Learn More on Akebia Therapeutics' current short interest. What is a good short interest ratio for Akebia Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AKBA shares currently have a short interest ratio of 4.0. Learn More on Akebia Therapeutics's short interest ratio. Which institutional investors are shorting Akebia Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Akebia Therapeutics: Jane Street Group LLC, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Akebia Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 9.58% of Akebia Therapeutics' floating shares are currently sold short. Is Akebia Therapeutics' short interest increasing or decreasing? Akebia Therapeutics saw a increase in short interest in the month of May. As of May 31st, there was short interest totaling 20,050,000 shares, an increase of 1.7% from the previous total of 19,720,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Akebia Therapeutics' short interest compare to its competitors? 9.58% of Akebia Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Akebia Therapeutics: Arcellx, Inc. (16.66%), Alvotech (1.42%), Protagonist Therapeutics, Inc. (9.24%), Catalyst Pharmaceuticals, Inc. (6.92%), Crinetics Pharmaceuticals, Inc. (11.71%), Viking Therapeutics, Inc. (25.15%), Scholar Rock Holding Co. (18.81%), Kymera Therapeutics, Inc. (12.09%), MoonLake Immunotherapeutics (11.92%), Immunovant, Inc. (31.62%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($64.96 billion), Invesco QQQ ($27.88 billion), iShares Russell 2000 ETF ($19.94 billion), iShares 20+ Year Treasury Bond ETF ($9.69 billion), Strategy Incorporated ($8.58 billion), SPDR S&P Biotech ETF ($5.72 billion), Invesco S&P 500 Equal Weight ETF ($5.45 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.70 billion), Charter Communications, Inc. ($4.54 billion), and Industrial Select Sector SPDR Fund ($4.49 billion). View all of the most shorted stocks. What does it mean to sell short Akebia Therapeutics stock? Short selling AKBA is an investing strategy that aims to generate trading profit from Akebia Therapeutics as its price is falling. AKBA shares are trading up $0.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Akebia Therapeutics? A short squeeze for Akebia Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of AKBA, which in turn drives the price of the stock up even further. How often is Akebia Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AKBA, twice per month. The most recent reporting period available is May, 31 2025. More Short Interest Resources from MarketBeat Related Companies ACLX Short Interest Data ALVO Short Interest Data PTGX Short Interest Data CPRX Short Interest Data CRNX Short Interest Data VKTX Short Interest Data SRRK Short Interest Data KYMR Short Interest Data MLTX Short Interest Data IMVT Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AKBA) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akebia Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Akebia Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
